Results 141 to 150 of about 4,771 (191)
SADRP: A structurally aware multi-modal framework for drug response prediction. [PDF]
Qi R +5 more
europepmc +1 more source
Alantolactone inhibits T-cell lymphoma progression by suppressing CD47 expression via the PI3K/AKT and ERK signaling pathways. [PDF]
Li X +8 more
europepmc +1 more source
<i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure. [PDF]
Xu ZM, Sluka JP, Zhang CC, Knipp G.
europepmc +1 more source
UGT Genotyping in Belinostat Dosing [PDF]
Certain genetic polymorphisms of UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1) can reduce gene expression (*28, *60, *93) or activity (*6), thereby altering the pharmacokinetics, pharmacodynamics, and the risk of toxicities of UGT1A1 substrates, of which irinotecan is a widely-described example.
William Douglas Figg, Jr.
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Simple and Efficient Synthesis of Belinostat
Synthetic Communications, 2010A novel synthesis of belinostat (1) starting from 3-nitrobenzaldehyde has been developed. The key step in this sequence involves the conversion of (2E)-3-(3-aminophenyl)acrylic acid methyl ester to (2E)-3-(3-chlorosulfonylphenyl)acrylic acid methyl ester via diazotization and sulfonylation.
Lei Yang, Xiaowen Xue, Yihua Zhang
exaly +3 more sources
ZL277 is a prodrug of belinostat with enhanced bioavailability and efficacy as a pan histone deacetylase (HDAC) inhibitor. In this study, we investigated the metabolism and pharmacokinetics of ZL277 in liver S9 fractions, liver microsomes, liver cytosol,
Changde Zhang +2 more
exaly +2 more sources
Belinostat: Clinical Applications in Solid Tumors and Lymphoma
Expert Opinion on Investigational Drugs, 2011Histone deacetylase (HDAC) inhibitors have recently emerged as a novel and active class of anticancer agents. Belinostat is one member of the class that has been tested as a single agent and in combination with other chemotherapies and biological agents in the treatment of solid tumors and lymphoma.A literature search of pre-clinical and clinical ...
Johann de Bono, L Rhoda Molife
exaly +3 more sources

